Vaccination with Two Doses of AstraZeneca^® (ChAdOx1-S) and Pfizer^® (BNT162b2) Induces the Production of Immunoglobulin G for COVID-19 Without Damaging Hematological, Biochemical, Inflammatory and Oxidative Biomarkers

Background: In 2019, a new virus caused by SARS-CoV-2, called COVID-19, spread throughout the world, causing a pandemic state. As the pandemic progressed and cases continued to increase, safe vaccines were developed for the entire population. In Brazil, AstraZeneca^® (ChAdOx1-S) and Pfizer...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Laura Smolski dos Santos, Genifer Erminda Schreiner, Elizandra Gomes Schmitt, Mariana Larré da Silveira, Camila Berny Pereira, Luana Tamires Maders, Silvia Muller de Moura, Mohammad Prudêncio Mustafá, Itamar Luís Gonçalves, Ilson Dias da Silveira, Vanusa Manfredini
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2026-01-01
Saila:	COVID
Gaiak:	SARS-CoV-2 Immunization Biochemistry
Sarrera elektronikoa:	https://www.mdpi.com/2673-8112/6/1/15
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!